• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors.

作者信息

Rezkallah Amina, Kodjikian Laurent, Malclès Ariane, Dot Corinne

机构信息

Department of Ophthalmology, Croix-Rousse Teaching Hospital, Hospices Civils de Lyon, 103 Grande rue de la Croix Rousse, 69004, Lyon, France.

Department of Ophthalmology, Desgenettes Military Hospital, 108 boulevard Pinel, 69003, Lyon, France.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):219-220. doi: 10.1007/s00417-017-3773-z. Epub 2017 Aug 11.

DOI:10.1007/s00417-017-3773-z
PMID:28801709
Abstract
摘要

相似文献

1
DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors.无危险因素患者的地塞米松植入物玻璃体内注射、持续性眼压升高和类固醇性青光眼
Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):219-220. doi: 10.1007/s00417-017-3773-z. Epub 2017 Aug 11.
2
SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.玻璃体内注射地塞米松植入剂（Ozurdex）的安全性：SAFODEX研究。高眼压症的发病率及危险因素。
Retina. 2017 Jul;37(7):1352-1359. doi: 10.1097/IAE.0000000000001369.
3
LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.地塞米松植入术后眼压升高的长期发生率及危险因素：SAFODEX-2 研究。
Retina. 2021 Jul 1;41(7):1438-1445. doi: 10.1097/IAE.0000000000003080.
4
XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.XEN 凝胶支架治疗地塞米松眼内注射后眼内高压：5 例报告。
J Glaucoma. 2019 Jan;28(1):e5-e9. doi: 10.1097/IJG.0000000000001092.
5
INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION.眼内曲安奈德植入原位与眼高压。
Retina. 2018 Dec;38(12):2343-2349. doi: 10.1097/IAE.0000000000001883.
6
Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.玻璃体内注射地塞米松植入物后眼压波动和继发性青光眼的发生：赞比亚的观点。
Pan Afr Med J. 2021 Jun 6;39:108. doi: 10.11604/pamj.2021.39.108.23528. eCollection 2021.
7
Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.常规临床实践中玻璃体内注射地塞米松植入术后继发性高眼压与青光眼手术风险
Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):680-685. doi: 10.3928/23258160-20180831-05.
8
Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.眼内类固醇注射后眼压升高的发生率、危险因素、治疗和转归：一项比较研究。
Ophthalmologica. 2022;245(5):431-438. doi: 10.1159/000522504. Epub 2022 Apr 25.
9
Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.玻璃体内注射0.7毫克地塞米松植入剂与2毫克曲安奈德后眼压升高情况比较
Semin Ophthalmol. 2020 Feb 17;35(2):141-146. doi: 10.1080/08820538.2020.1758161. Epub 2020 Apr 28.
10
OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.在3个治疗周期内观察到地塞米松玻璃体内植入物治疗视网膜静脉阻塞性黄斑水肿的并发症。
Retina. 2015 Aug;35(8):1647-55. doi: 10.1097/IAE.0000000000000524.

引用本文的文献

1
What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant?在过去十年中，使用0.19毫克曲安奈德玻璃体内植入物治疗糖尿病性黄斑水肿患者，我们学到了什么？
Eye (Lond). 2025 May;39(7):1238-1248. doi: 10.1038/s41433-025-03692-7. Epub 2025 Feb 19.
2
Clinical prediction nomogram for steroid-induced ocular hypertension risk in patients with intravitreal dexamethasone implant.玻璃体内地塞米松植入患者类固醇性高眼压风险的临床预测列线图
Heliyon. 2024 Jul 15;10(14):e34635. doi: 10.1016/j.heliyon.2024.e34635. eCollection 2024 Jul 30.
3
Impact of systemic steroids combined with immunosuppressive treatment on glaucomatous features in patients with systemic lupus erythematosus.

本文引用的文献

1
SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.玻璃体内注射地塞米松植入剂（Ozurdex）的安全性：SAFODEX研究。高眼压症的发病率及危险因素。
Retina. 2017 Jul;37(7):1352-1359. doi: 10.1097/IAE.0000000000001369.
2
TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA.玻璃体内地塞米松植入物在高眼压或开角型青光眼患者中的耐受性
Retina. 2017 Jan;37(1):173-178. doi: 10.1097/IAE.0000000000001114.
3
[Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
全身用类固醇联合免疫抑制治疗对系统性红斑狼疮患者青光眼特征的影响。
Int J Ophthalmol. 2022 Jan 18;15(1):71-76. doi: 10.18240/ijo.2022.01.11. eCollection 2022.
4
Sodium 4-Phenylbutyrate Reduces Ocular Hypertension by Degrading Extracellular Matrix Deposition via Activation of MMP9.苯丁酸钠通过激活 MMP9 降解细胞外基质沉积来降低眼内压。
Int J Mol Sci. 2021 Sep 18;22(18):10095. doi: 10.3390/ijms221810095.
5
Current intravitreal therapy and ocular hypertension: A review.当前的眼内治疗和眼压升高：综述。
Indian J Ophthalmol. 2021 Feb;69(2):236-243. doi: 10.4103/ijo.IJO_1028_20.
6
Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab.3年期治疗并延长方案后眼压持续升高：阿柏西普与雷珠单抗对比
J Ophthalmol. 2020 Jan 20;2020:7462098. doi: 10.1155/2020/7462098. eCollection 2020.
7
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis.地塞米松玻璃体内植入物在视网膜静脉阻塞或非感染性后段葡萄膜炎患者中安全性的上市后监测研究。
Clin Ophthalmol. 2018 Dec 6;12:2519-2534. doi: 10.2147/OPTH.S181256. eCollection 2018.
玻璃体内注射类固醇后眼压升高：2015年临床最新进展
J Fr Ophtalmol. 2015 Sep;38(7):656-64. doi: 10.1016/j.jfo.2015.03.002. Epub 2015 Jun 19.
4
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.为期三年的随机、假手术对照试验：地塞米松眼内植入物治疗糖尿病性黄斑水肿患者。
Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4.
5
EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. II. THE EFFECT OF DEXAMETHASONE IN THE GLAUCOMATOUS EYE.皮质类固醇对眼压和流体动力学的影响。II. 地塞米松对青光眼患眼的影响。
Arch Ophthalmol. 1963 Oct;70:492-9. doi: 10.1001/archopht.1963.00960050494011.